Table: Haba Laboratories Inc -Q1 group results
Aug 14 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2025 Jun 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.63 2.67 12.55
(-1.6 pct) (+3.9 pct) (+4.0 pct)
Operating 60 mln loss 37 mln 500 mln
(-15.2 pct)
Recurring 58 mln loss 29 mln 490 mln
(-19.5 pct)
Net 41 mln loss 22 mln 480 mln
(-16.7 pct)
EPS 10.87 yen loss 5.88 yen 126.93 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T